There's an enigmatic chair of cardiology at Case? I thought they didn't have one??
As below it seems like:
1) Yes, he is going to Case
2) He'll be at Case for a little while, probably at least a couple of years (the $17 million grant and everything)
3) But he will have no involvement in clinical medicine. So no, he won't be chair of cardiology at Case or even involved in the department of cardiology, just another researcher at Case Western's medical school.
ABC News:
http://abcnews.go.com/Business/wireStory?id=1602398
"Dr. Eric Topol, the world-renowned cardiologist who challenged the safety of the pain reliever Vioxx, is leaving The Cleveland Clinic to become a genetics professor."
The Plain Dealer (Cleveland's paper):
http://www.cleveland.com/news/plaindealer/index.ssf?/base/news/1139564696314050.xml&coll=2
"Wrapping up 15 years of growth and prestige for the Clinic in cardiology, the sometimes-controversial Topol is moving down the street to Case Western Reserve University, where he will continue to lead a $17.2 million research project."
"The job at Case is likely to be a way station for a man who is, by all accounts, one of the most influential cardiologists of a generation."
"He said his clinical work with patients will be suspended."
"Dr. Ralph Horwitz, dean of the Case medical school, said he first talked about the move with Topol on Saturday. Topol already is on the faculty at Case. When the deal is finished, his sole appointment will be in its department of genetics."
"Discussions about how the 51-year-old Topol would exit the Clinic have been under way for weeks, ever since he was stripped of his dual positions as chief academic officer and provost. Clinic leaders seemed to want Topol out, people familiar with the situation said. Topol, meanwhile, was said to be considering other positions."
Crain's Cleveland Business:
http://www.crainscleveland.com/apps/pbcs.dll/article?AID=/20060209/FREE/60209001/1007
"In an interview with Crains Cleveland Business, Dr. Topol said he will become a professor in the Department of Genetics, where hell teach and conduct research. But he added that he has no plans to practice medicine, either at University Hospitals of Cleveland or MetroHealth Medical Center, both of which have strong ties to the Case medical school."
"(Practicing medicine) is not in my plans at the moment, he said. I have no plans to be at UH or Metro."
"Dr. Topol said he will continue his genetics research, which is financed by a $17 million grant from the National Institutes of Health. "
